BETTER THERAPEUTICS, INC.
CIK 0001832415
Revenue (TTM)
$8K
Q3 Nov 2023
Net Income (TTM)
−$34.21M
+1.4% YoY
Q3 Nov 2023
EPS Diluted (TTM)
−$1.26
+45.7% YoY
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
-403,587.5%
Q3 Nov 2023
Net Margin
-427,662.5%
Q3 Nov 2023
Free Cash Flow (TTM)
−$22.97M
Q3 Nov 2023
Cash
$6.6M
Q3 Nov 2023
Total Debt
$14.31M
Q3 Nov 2023
Shares Outstanding
47.4M sh
Q3 Nov 2023
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.